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Abstract
Background: To identify publicly available internet resources and assess their likelihood to support women
making informed decisions about, and between, fertility preservation procedures before starting their cancer
treatment.
Methods: A survey of publically available internet resources utilising an environmental scan method. Inclusion
criteria were applied to hits from searches of three data sources (November 2015; repeated June 2017): Google (Chrome)
for patient resources; repositories for clinical guidelines and projects; distribution email lists to contact patient decision aid
experts. The Data Extraction Sheet applied to eligible resources elicited: resource characteristics; informed and shared
decision making components; engagement health services.
Results: Four thousand eight hundred fifty one records were identified; 24 patient resources and 0 clinical
guidelines met scan inclusion criteria. Most resources aimed to inform women with cancer about fertility
preservation procedures and infertility treatment options, but not decision making between options. There
was a lack of consistency about how health conditions, decision problems and treatment options were
described, and resources were difficult to understand.
Conclusions: Unless developed as part of a patient decision aid project, resources did not include
components to support proactively women’s fertility preservation decisions. Current guidelines help people
deliver information relevant to treatment options within a single disease pathway; we identified five additional
components for patient decision aid checklists to support more effectively people’s treatment decision making
across health pathways, linking current with future health problems.
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Background
Providing accurate patient information is fundamental to
health services worldwide [1]. Since the 1940s, social sci-
ence research has informed guidance to enhance text
readability [2, 3] and health communications [4, 5]. Na-
tional and academic organisations provide best practice
guidance [6] for patient-focused intervention develop-
ment and evaluation [7, 8]. Research indicates patient re-
sources informed by these standards enhance health
literacy and patient benefits [9]. A challenge for service
delivery is to support patient-focused communications
about complex health problems; most guidance support
one-off decisions about a health problem in a single
pathway of care [10].
An iatrogenic consequence of cancer treatment is an in-
creased chance of impaired fertility; treatments can per-
manently damage the endocrine function and/or
reproductive systems needed to fall pregnant or carry a
baby to term [11]. Oncologists deliver care to minimise
these fertility-related effects using minimally gonadotoxic
therapies [12] and/or fertility sparing procedures (e.g.
trachelectomy, ovarian transpositioning, shielding) [13,
14]. For some women with impaired fertility after cancer
treatment, infertility treatments are offered [15]. Having
fertility preservation procedures before cancer treatment
may increase the likelihood of women having genetically
related children in the future, but can delay the start of
cancer treatment by a few weeks. Fertility services offer
the following preservation procedures: embryo cryopreser-
vation, oocyte cryopreservation, and ovarian tissue cryo-
preservation [16, 17].
Integrating relevant fertility preservation information
into cancer pathways is essential for women to make in-
formed decisions about whether to undergo fertility
preservation, and/or which procedures to choose [15,
18–25]. Receiving accurate and timely information is as-
sociated with reported better quality of life and reduced
decisional regret, post cancer treatment [22, 26–29].
However, women’s recall of discussions with health pro-
fessionals and support about infertility-related side-ef-
fects of cancer treatment is low [18, 30, 31]; findings
indicate variation in the timing, content, utility and
quantity of information about fertility preservation pro-
vided by cancer services [18, 31–33].
Increasingly the internet is accessed for health infor-
mation [34–38], and people find resources from stake-
holders independent of healthcare services (e.g. public,
professionals, charities, advocacy groups, product adver-
tisers, unregulated businesses) and in varied formats
(e.g. audio, video, text). These resources may provide ac-
curate information to support patient and carer health
literacy, or they may be misleading and difficult to
understand in the context of a person’s life, experience
and illness. It is unclear if and how systematically best
practice guidance are used to inform publically available
resources [39, 40]. This paper investigates what publi-
cally available resources are available to women about
fertility preservation choices before starting their cancer
treatment, and if they are sufficient to enable informed
decision making.
Methods
We carried out a survey of publically available patient
information and guideline resources to support women
diagnosed with cancer making fertility preservation
choices before treatment. We employed an environmen-
tal scan method used in applied health research for sys-
tematic analysis of Google search engine, targeted
website searches and contacting experts [41–44]. We
used this approach to search for resources freely avail-
able to any woman or health professional [34–38, 44];
internet searches can be more effective at identifying re-
ports [42] and informal material relevant to the topic
than academic or organisational databases [45, 46].
We followed the PRISMA reporting guidelines for best
practice in reporting systematic reviews of secondary
data synthesis [47]. These guidelines provide steps to en-
courage methodological rigour around the search, inclu-
sion criteria, extraction and synthesis of findings. The
target for this environmental scan is a resource (leaflet
or guideline) rather than an empirical study; the quality
of the target is judged against criteria known to boost
reasoning rather than those known to enhance meth-
odological rigour. A data extraction sheet was developed
to elicit systematically the key characteristics and con-
tent from each resource, which are described in tables
and synthesised within the results section.
Study context
This survey was carried out during the development phase
of the Cancer, Fertility and Me Patient Decision Aid
(CFM-PtDA) [48–50]. Other activities included (Nov
2015-Sept 2016): research governance and ethics; scoping
local and national patient information provided during
usual care by services to patients with cancer; mapping care
pathways between cancer and fertility services in Leeds and
Sheffield, UK; alpha testing [51] the CFM-PtDA prototype
with patients, oncology healthcare professionals and
other key stakeholders using qualitative methods. The
project received ethics approval by National Health
Service (NHS) Health Research Authority (HRA), East
Midlands Nottingham 1 Research Ethics Committee
in 2016, Ref: 16/EM/0122; HRA Ref:194751.
Information sources and search strategies
Health information is provided and used for different
purposes, such as to inform, reassure, persuade, ac-
quire skills and enhance reasoning [52–54]. We
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searched the internet for resources with minimum
standards for patient decision aids known to support
understanding of the health problem [4, 55, 56]; pro-
vide awareness of the advantages and disadvantages of
all relevant treatment options and their consequences
[52]; and support reasoned decision making [17, 52–
54]. These include components known to minimise
bias through providing balanced, neutral information
of all options and presentation of risk as natural fre-
quencies/ percentages [57–61]; a visual representation
of the decision problem [10, 62]; an evaluation of
these details in accordance with a person’s values [63–
66]; an explanation of people’s understanding of illness
and treatment [4, 55, 56, 67]; and allow for an in-
formed decision to be reached and implemented with
health professionals [59, 63, 68].
Three types of data source were searched between
November 11th – December 17th 2015, and repeated
in June 2017. Search terms, Uniform Resource Loca-
tor (URL) identifiers, and hits were managed using
Excel [42]:
1. Google (Chrome) was searched using 8 unique
search themes (cancer, breast cancer, leukemia,
lymphoma, gynaecological, surgery, radiotherapy,
chemotherapy), developed with an information
specialist (NVK). Within those themes there were 9
unique strategies which contained multiple
combinations of the following terms (UK and USA
spellings): cancer (all types); women (patient);
treatment (procedure); fertility preservation
(treatment); decision-making; information (booklet,
education, decision aid) (contact authors for further
information). All internet web-links, including spon-
sored links, on the first 5 pages of each search were
screened (n = 3600 websites) [42].
2. Open access repositories of patient decision aids,
clinical guidelines and active research were
searched using five search strategies developed with
an information specialist (NVK): Decision Aids
Library Inventory (DALI, Ottawa Health Research
Institute, Canada) (https://decisionaid.ohri.ca/
cochinvent.php); Trip clinical search engine https://
www.tripdatabase.com/); Clinical guidelines database-
NICE Evidence; (https://www.evidence.nhs.uk/);
Agency for Healthcare Research and Quality
National Guidelines Clearinghouse - AHRQ-NGC;
(https://www.guideline.gov/); UK and USA Clinical
trials databases (https://www.ukctg.nihr.ac.uk/;
https://clinicaltrials.gov/).
3. Experts (health professionals, patients and
researchers) in patient decision aid and shared
decision-making interventions and research were
contacted via the SHARED-L international email
distribution list. Experts were not asked to participate
in the study, but to simply email the study team with
information on any patient resources and guidelines
which met the study criteria. Four experts responded
by 31st January 2016, and all open-access resources
identified (n = 4) were included in the study.
Data selection
Patient resources with the following criteria were
included:
 Targeted women diagnosed with cancer and offered
fertility preservation options,
 Described fertility problems as a consequence of
cancer treatment,
 Described fertility preservation options and
consequences
 Contained an explicit statement to consider fertility
preservation options before cancer treatment.
Clinical guidelines with the following criteria were
included:
 Raised awareness of the link between cancer
treatment and fertility problems
 Contained explicit guidance on what fertility
preservation options to mention to women
diagnosed with cancer
 Explained the links between the fertility and cancer
management pathways
 Provided explicit guidance on how to support
women’s choices about fertility preservation options
in the context of their cancer care.
All resources were screened (NM) for inclusion in
the study; NM and HLB discussed decisions about re-
sources, included (n = 10), excluded (n = 10) and un-
certain (all). The search process and criteria were
discussed independently with GLJ, JH (November
2015).
Data extraction
A data extraction sheet (Additional file 1) was
developed (HLB, NM) with reference to patient deci-
sion aid research reviews and resource development
[2, 7, 8, 10, 35, 52–54, 69, 70], and cancer-related fer-
tility preservation decision aids [22, 26, 27, 29, 71, 72].
The presence or absence of minimum standards and
components know to support understanding of the
health condition, decision problem, treatment options
and their consequences, and reasoned decision making
were extracted systematically from each resource
meeting the scan’s inclusion criteria using the data ex-
traction sheet. The Data Extraction Sheet was piloted
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(NM, JH, GLJ), independently reviewed by the
CFM-PtDA project steering group (February 2016),
and applied systematically to eligible resources (NM,
JH) extracting the following:
 Characteristics: type of ‘e-resource’ (internet-
delivered, internet-adapted, internet-available) [35],
title, publisher, year of publication and of the
updated year, country, authors, funders, location
(URL), length, stated purpose resource.
 Quality indicators: Flesch readability formula [3] was
used to measure comprehensibility of leaflet (70–79
fairly easy; 60–69 standard; 50–59 fairly difficult;
30–50 difficult; 0–29 confusing), endorsed by third
party, developed systematically, listed evidence used
to inform content.
 Describes health problem: label and symptoms,
cause, time-line, consequences, cure and/or control,
and emotional responses to a) cancer, b) fertility /
infertility, and c) cancer-related infertility.
 Describes treatments: label /procedure, eligibility,
prognosis, side effects short term, side effects long
term for cancer treatment (chemo/ radio/ hormone
therapy, surgery), fertility preservation treatments
(egg/ embryo/ ovarian freezing, ovarian suppression/
shielding), and/or infertility treatments
(in vitro fertilisation, adoption/ fostering,
surrogacy).
Fig. 1 Study flow diagram - Resource and guideline identification, screening, and eligibility
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 Signposts illness-wellness trajectory: care pathways;
quality of life.
 Decision architecture to boost/ bias thinking:
trade-offs between options; decision picture;
decision guidance; other’s values/ stories; risk
presentation; treatment preference.
 Health service engagement: prompts to prepare for
consultations, friends and families; diagrams/
guidance to prepare for procedures; signposting to
other information.
Data synthesis and analysis
Two quality-assessment grids were applied to synthesise
evidence across resources: The IPDAS grid - 12 compo-
nents identified as minimum criteria for a patient deci-
sion aid resources [8, 9, 44, 69, 70]; Informed Decision-
Making (IDM) grid - 10 components known to boost in-
formed and shared decision-making, and minimise rea-
soning bias [52–54]. Each item scored either 0 (present)
or 1 (not present); Summed total scores were IPDAS
grid (0–12), and IDM grid (0–10).
The findings are presented using narratives and fre-
quency statements to address whether or not women
and health professionals have access to publicly available
online resources that support fertility preservation deci-
sions before cancer treatment. SPSS statistical software
was used to manage the data elicited from the resources.
Descriptive data were used to assimilate findings across
resources, and show the number of occurrences for each
component on the data extraction sheet.
Results
Shown in Fig. 1, the search yielded 147 unique records
eligible for assessment (n = 116 e-resources and n = 31
guidelines). Following screening, none of the 31 guide-
lines met the scan’s inclusion criteria (Table 1); although
all guidelines make links between the consequences of
cancer treatment and fertility problems, only 7 highlight
guidance around availability of fertility preservation
treatments, only 5 made links between cancer and fertil-
ity management pathways for women, and none pro-
vided guidance for professionals on how to support
women’s decision making about fertility preservation op-
tions in the context of their cancer care.
Following screening, 24 patient resources met the
scan’s inclusion criteria (Table 2). Most resources were
suitable for women with any cancer type (n = 16), and
most were designed for adults (n = 16). Resources were
published between 2005 and 2017, all but one (SN22) in
English, one (SN24) was judged as fairly easy to read,
and one (SN22) was internet-adapted by using an inter-
active web-based platform (Table 2). All resources stated
their publisher, thirteen described the development
team, ten included references of the evidence-base
informing the resource content, four stated they were
endorsed by a third party, three published peer-reviewed
papers demonstrating the resource’s development and/or
evaluation, and two were located on the publicly avail-
able DALI (Table 3).
Meeting minimum standards for patient decision aid
resources
All resources eligible for the study provided information
about the health conditions and treatment options
(Table 4). The stated aim for 18 resources was to provide
information about cancer, fertility and infertility options;
7 stated their purpose was to support making a decision
between treatment options (SN8, SN10, SN11, SN12,
SN18, SN22, SN24). Of these, 3 focused on decisions be-
tween having cancer treatment with or without fertility
preservation (SN2, SN3, SN23), 3 between fertility pres-
ervation options (SN22, SN23, SN24), and 2 between in-
fertility treatments to have a family (SN22, SN24).
All 24 resources encouraged women to talk to their
cancer care and/or fertility specialist teams, and/or speak
with friends and family; 15 (SN3, SN6, SN7, SN8, SN11,
SN13, SN14, SN16, SN18, SN19, SN20, SN21, SN22,
SN23, SN24) provided questions to support shared deci-
sion making in consultations with health professionals.
No resources included all the components identified as
part of the minimum standards for a patient decision aid
[9]; the median score was 4 out of 12 points (range 2–8)
(Table 4).
Inclusion of components boosting or biasing informed
decision-making
There were variations in how cancer and fertility problems
were described across resources (Table 5), with gaps in de-
tails to help women’s understanding of the causal links be-
tween having cancer treatment and an increased
likelihood of having fertility problems in the future. Most
resources (n = 21) described fertility-related options be-
fore, during and after cancer. Four (SN14, SN22, SN23,
SN24) resources used flow diagrams to illustrate links be-
tween choices and service delivery pathways. Seven pro-
vided diagrams and pictures to explain procedures (e.g.
In-vitro fertilisation) (SN1, SN2, SN7, SN10, SN12, SN23,
SN24) and six illustrated body systems (e.g. reproductive
system) (SN1, SN7, SN10, SN11, SN12, SN23).
There was variation in the amount of information
given about treatment options for the short and long-
term consequences of cancer-related fertility (Table 6).
Ten resources included prompts encouraging women to
describe what was important to them about infertility-
treatment options (Table 7); one provided quality of life
statements to help women’s reasoning (SN7). Three re-
sources used an option-by-attribute table format to sum-
marise details (SN5, SN23, SN24), and two used
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trade-offs based on their values (SN22, SN24). The
health professionals’ opinion was provided in two re-
sources (SN1, SN6), and other women’s stories about
their experiences in four resources (SN1, SN7, SN14,
SN24).
Resources provided risk statements about: cancer treat-
ment side effects; cancer treatment impact on fertility; fertil-
ity preservation side effects to women and/or the baby; risk
of cancer reoccurrence; success of fertility preservation treat-
ments. Usually risk was presented as a verbal descriptor (e.g.
low, high, likely) (n= 24), nine used percentages (SN2, SN6,
SN8, SN15, SN16, SN18, SN19, SN22, SN24) and/or figures
with the same common denominator across the resource
(e.g. 1 in 100) (n= 1) (SN1), and three used graphs, bar
charts and iconography figures (SN12, SN22, SN24). None
provided information about the levels of uncertainty around
event or outcome probabilities. Few provided balanced de-
tails about the risks and benefits of fertility preservation op-
tions; three (13%) described positive features (benefits)
(SN17, SN19, SN24), and eight (33%) negative features
(harms) (SN2, SN4, SN5, SN12, SN17, SN19, SN22, SN24).
No resources included all the components identified for
boosting informed and shared decision making [52–54]; the
median score was 3 out of 10 points (range 2–8) (Table 7).
Discussion
The search strategies identified 4851 cancer and fertility
resources (Fig. 1). It took six weeks of systematic analysis
to identify those integrating fertility preservation options
within the cancer care pathway. Those meeting the scan’s
Table 3 Assessment of Resource Development Quality (n = 24)
Development Process Item Study Number of Resource Number of resources
including component
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Publishers
Service providers x x x x x x x 7
Charity organisation x x x x x x x x x 9
Mixed (service, charity,
academic)
x x x x x x 6
Pharmaceutical companies x x 2
Stakeholders
Communication or decision
scientist
x x 2
Charity representative x x x x x 5
Patient or advocacy groups x x x x x 5
Fertility professional x x x x x x x x 8
Cancer professionals x x x x x x x x x x 10
Primary healthcare professionals x x x x x x x 7
Pharmaceutical organisation x 1
Applied researchers x x x x 4
Health care professional
organisation
x x x x x x 6
Endorsement Referenced In Resource
Information standard x x 2
Professional body 0
Patient advocacy x x 2
IPDAS endorsement 0
Evidence-Base Referenced In Resource
Evidence-based publication in
resource
x x x x x x x x x x 10
Quality Publication About Resource
Publication of development/
evaluation
x x x 3
Located on recognised
repository (DALI)
x x x 3
Mahmoodi et al. BMC Medical Informatics and Decision Making          (2018) 18:104 Page 10 of 16
criteria were predominantly information resources for
women with cancer, raising awareness of fertility preserva-
tion and informing about infertility treatment options. De-
tails describing the two related health problems, cancer
and fertility problems, varied across resources. Three re-
sources met the minimum criteria for recognition a pa-
tient decision aid [7, 9]; all three were developed and
evaluated within research projects. Six used components
and structures known to help people think actively about
treatment options in accordance with their own values
(Tables 4 and 7). No clinical guidelines enabled cancer
professionals to prepare women for fertility preservation
decisions and/or service referral; guidance was to read
quality standards and/or clinical guidelines for treating
fertility problems [15, 19]. As health professionals are not
provided with guidance on enabling fertility preservation
decisions in the context of cancer rather than infertility
treatment, and relevant patient information is not easily
accessible, these results explain in part why women with
cancer feel simultaneously unsupported and overwhelmed
by information at this time-pressured point in their treat-
ment management [18, 22, 28, 29, 31, 73].
Table 4 Resource assessed for inclusion of components within Patient Decision Aid Resources (IPDAS) (n = 24) [8, 69, 70]
IPDAS Checklist Item Study Number of Resources
Including Component
Number of resources
including component
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
1. Describes health condition for
index decision
x x x x x x x x x x x x x x x x x x x x x x x x 24
2. Explicitly describes the index
decision being considered
x x x x x x 6
3. Describes the options x x x x x x x x x x x x x x x x x x x x x x x x 24
4. Describes positive features all
options
x x x 3
5. Describes negative features all
options
x x x x x x x x 8
6. Describes what it is like to
experience the psychosocial
consequences of options
0
7. Shows negative and positive
features of all options in equal
detail (text amount, equal stats/
consequences)
x x 2
8 Cites evidence used or links to
document
x x x x x x x x x x 10
9. Provides a publication date
resource
x x x x x x x x x x x x x x 14
10. Provides information about an
update policy
x x x x x x x x x x 10
11. Provides information about
uncertainty level around event
/outcome probabilities
0
12. Provides information about the
funding source used for
development
x x x x x x x 7
Total score IPDAS (out of 12) 5 6 5 6 6 3 4 4 3 4 3 4 2 6 3 2 7 4 4 3 2 8 5 8
Table 5 Details of health conditions described, by illness-schemata category (n = 24) [56]
Cancer
(16/24)
Fertility
(14/24)
Infertility
(13/24)
Cancer-Related
Infertility (24/24)
Label/symptom 3 (13%) 7 (29%) 4 (17%) 9 (38%)
Timeline 1 (4%) 6 (25%) 5 (21%) 21 (88%)
Cause 2 (8%) 11 (46%) 2 (8%) 14 (58%)
Consequence 15 (63%) 3 (13%) 5 (21%) 19 (79%)
Cure/control 5 (21%) 1 (4%) 7 (29%) 17 (71%)
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Using the environmental scan method provided a
rigorous way to identify fertility preservation resources
[42, 74]. Our data extraction sheet enabled us to critique
resources systematically against established quality stan-
dards for written information [2, 4, 8, 69, 70]. However,
there are limitations to using these type of web-based
methods that may impact on our findings. Retrieving all
resources is difficult due to the volume of material avail-
able on the internet [42, 46] and the lack of archiving
and differing terminology used by developers [42]. Web-
site content and location can change over time [75] and
Google search algorithms and personalisation features
Table 6 Treatments described across resources for cancer and fertility problems (n = 24)
Cancer Treatment Fertility Preservation Options
Chemotherapy 23 (96%) Egg freezing 22 (92%)
Radiotherapy 23 (96%) Embryo freezing 23 (96%)
Surgery 17 (71%) Ovarian tissue freezing 21 (88%)
Hormone therapy 8 (33%) Ovarian suppression 13 (54%)
Targeted therapy 4 (17%)
Ovarian suppression as part of cancer treatment 5 (21%)
Family Planning During Cancer Infertility Treatment/ Family
Planning After Cancer
Contraception 11 (46%) Natural 17 (71%)
Assisted conception 17 (71%)
Surrogacy 16 (67%)
Adoption / fostering 15 (63%)
Contraception 12 (50%)
Table 7 Resource assessed for components boosting or biasing informed and shared decision making (I/SDM) (n = 24) [52–54]
I/SDM Component Study Number of Resources including Component Number of resources
including component
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
1. Provides accurate information
about all options (IDM)
x x x x x x x x x x x x x x x x x x x 19
2. Helps people think about what
matters to them about the options
(IDM)
x x x x x x x x x x 10
3. Supports reasoning about all
options without bias (IDM)
x x x x x 5
4. Presents figures in ways to
support understanding (IDM)
x x 2
5. Encourages people to trade-off
their evaluations to make a choice
(IDM)
x x 2
6. Encourages people to share
reasoning with their health
professionals (SDM)
x x x x x x x x x x x x x x x x x x x 19
7. Focuses thinking about the
decision in the context of their
lifestyle (IDM)
x 1
8. Places the decision in the
context of a changing illness-
health state (IDM)
x x x x x x x x x x x x x x x x x x x x x 21
9 Enables decision to be
implemented within care pathway
(SDM)
x 1
10. Encourages comparisons
between different decisions (IDM)
x x x x 4
Total Judgement score (out of 10) 2 2 3 4 3 4 5 2 3 3 2 5 2 3 2 3 3 3 3 3 3 7 5 8
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linked to geographical location and previous search his-
tory all influence the results retrieved [42, 46, 75]. Ideally
more than one search engine should be searched as they
use different algorithms affecting relevance rankings and
subsequent resource retrieval [76], patients also use dif-
ferent browsers or search engines. Best practice guidance
for internet searches is developing [41], conducting an
environmental scan using three complementary search
strategies and repeating the Google search a year later
from a different organisation should help to minimise
the risk of missing key resources and address some of
the bias in our search methods [42, 44, 74].
From our synthesis and critical evaluation of re-
sources, we identified components likely to support pro-
actively women’s health literacy and reasoning in
decisions which cross medical specialty. First, explicit la-
belling linking the current illness with the future health
problem (e.g. cancer-related fertility problem) helps es-
tablish causality between the current treatment and its
iatrogenic consequence. Second, including details
describing the future health across all illness representa-
tion dimensions (label/ symptoms, cause, time-line, con-
sequences, cure/control) to enable women to have a
coherent understanding of the short and long-term
cancer-related fertility problems arising. Third, describ-
ing the fertility preservation decisions, and presenting all
options with equivalent and balanced information, to en-
able stakeholders to focus on details relevant for women
having cancer treatment. Fourth, signposting to other
fertility-related choices within the cancer treatment tra-
jectory raises awareness for women’s involvement at the
right time in the cancer pathway [48] (Fig. 2). Fifth, de-
scribe risk figures and elicit preferences about the fertil-
ity preservation options to focus the discussion on
information relevant to the context of starting, and
minimising the consequences of, cancer treatment. Sev-
eral resources encouraged women to rate their prefer-
ences for in-vitro fertilisation, surrogacy, adoption and
fostering, i.e. options for women receiving treatment for
fertility problems. People’s’ preferences are labile [77],
Cancer diagnosis and treatment planning
Fertility preservation decisions before cancer treatment
Not to preserve fertility Freezing Ovarian supression
Egg Embryo Tissue
Cancer treatment and care
Contraception during cancer treatment
Barriers 
(condom, 
diaphragms)
IUD
(coil, intrauterine 
device)
Hormone 
(pill, implant, 
injection)
Abstinence 
(not sexually 
active)
Cancer follow-up and monitoring
Family planning decisions after cancer treatment
Contraception
Having children 
with pregnancy
Having children 
without pregnancy
Using own 
frozen eggs/ 
embryo/tissue
Natural
Donor 
eggs or 
embryo
Surrogacy Adoption Fostering
Fig. 2 Decision map integrating fertility options within cancer-care pathway [48]
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and eliciting women’s values towards children,
life-partners, and infertility treatments before they have
a fertility problem, and whilst they are ill with cancer,
may have limited value to making a decision about fertil-
ity preservation when being treated for cancer.
Conclusions
Achieving patient-centred integrated cancer care requires
effective communication between patients and profes-
sionals [23, 68, 78]. Current clinical guidelines, patient re-
sources, and patient decision aid frameworks provide little
guidance enabling services to provide standardised infor-
mation supporting cross-specialty decisions about health
options. In consequence, there is variation in what infor-
mation women receive within cancer services about fertil-
ity preservation, and can access from web-sites. We
suggest components based on our study’s synthesis and
critical evaluation can be used in resource development
guidance to inform the content and structure of patient
resources, clinical guidelines and shared decision making
training to support more effectively women making fertil-
ity preservation decisions before starting their cancer
treatment. Providing an infrastructure to ensure adoption
and maintenance of rigorously developed and evaluated
patient decision aids in relevant repositories is likely to in-
crease women’ access to appropriate resources [79]. As is
raising awareness and skills of utilising social science evi-
dence when developing and designing patient information
and professional guidelines to support people making
healthcare decisions.
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